Pharmeca.cz

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant BIOGEN IDEC LIMITED, Teva Pharmaceuticals CR, s.r.o., Merck Serono Europe Limited, against the decision of the State Institute for Drug Control from 29. 3. 2018, under the no. SUKLS81849/2014 - The decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.

More information: MZCR.cz (czech version only)

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Egis Pharmaceuticals PLC, against the decision of the State Institute for Drug Control from 21. 4. 2017, under the no. SUKLS52988/2017 - Under article 90 paragraph 1 letter b) of the Administrative Code the operative part 6 – 13 of the decision under appeal is dismissed and the issue is referred back to the State Institute for Drug Control for reappraisal.

More information: MZCR.cz (czech version only)

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Svaz zdravotních pojišťoven, against the decision of the State Institute for Drug Control from 29. 3. 2018, under the no.  SUKLS101873/2014 - I. Under article 90 paragraph 4 in connection with article 66 paragraph 2 of the Administrative Code the operative part no. 24 of the decision under appeal is dismissed and the proceedings are terminated. II. Under article 90 paragraph 5 of the Administrative Code the operative part 2 - 23, 25 - 35 of the decision under appeal is dismissed and the part of the decision under appeal is upheld.

More information: MZCR.cz (czech version only)

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Allergan Pharmaceuticals Ireland, against the decision of the State Institute for Drug Control from 21. 3. 2017, under the no. SUKLS142216/2014 - the decision under appeal is dismissed and the proceedings are terminated.

More information: MZCR.cz (czech version only)

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Svaz zdravotních pojišťoven, against the decision of the State Institute for Drug Control from 28. 3. 2017, under the no. SUKLS45597/2014  - I. Under article 90 paragprah 1 letter b) of the Administrative Code the operative part 1, 3, 9, 10, 11a, 11b, 12, 13, 14a and 14b The decision is reversed and the matter is referred back to the State Institute for Drug Control for reappraisal.

II. Under article 90 paragraph 5 of the Administrative Code the part of the appeal is dismissed and the rest of the decision 2, 15, 16, 17, 18, 19 and 20 under appeal is upheld.

More information: MZCR.cz (czech version only)

 

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of Prices and Reimbursements for Medicinal Products and Foods for Special Medicinal Purposes (“List”).

 

Více na: EN SUKL - List of reimbursed medicinal products

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Pfizer, spol. s r.o., against the decision of the State Institute for Drug Control from 30. 3. 2017, under the no. SUKLS167400/2016. The appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz (czech version only)

 

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of Prices and Reimbursements for Medicinal Products and Foods for Special Medicinal Purposes (“List”).    

 

Více na: EN SUKL - List of reimbursed medicinal products